BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 27630936)

  • 1. A Study on Dosimetric Outcomes and Acute Toxicity of Post Mastectomy Adjuvant Hypofractionated Radiotherapy for Breast Cancer.
    Deshmukh S; Sharan K; Fernandes DJ; Srinivasa VM; Yathiraj PH; Singh A; Reddy A
    J Clin Diagn Res; 2016 Jul; 10(7):XC05-XC08. PubMed ID: 27630936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Phase 2 Study of 2 Weeks of Adjuvant Whole Breast/Chest Wall and/or Regional Nodal Radiation Therapy for Patients With Breast Cancer.
    Yadav BS; Sharma SC
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):874-881. PubMed ID: 29485066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypofractionated radiation treatment following mastectomy in early breast cancer: the Christchurch experience.
    Ko DH; Norriss A; Harrington CR; Robinson BA; James ML
    J Med Imaging Radiat Oncol; 2015 Apr; 59(2):243-7. PubMed ID: 25287654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypofractionated radiotherapy for breast cancers--preliminary results from a tertiary care center in eastern India.
    Nandi M; Mahata A; Mallick I; Achari R; Chatterjee S
    Asian Pac J Cancer Prev; 2014; 15(6):2505-10. PubMed ID: 24761855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypofractionated radiotherapy after breast-conserving surgery: Clinical and dosimetric factors predictive of acute skin toxicity.
    Ben Amor R; Bohli M; Naimi Z; Aissaoui D; Mejri N; Yahyaoui J; Hamdoun A; Kochbati L
    Strahlenther Onkol; 2023 Jan; 199(1):48-54. PubMed ID: 35943552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypofractionated Radiation Therapy (HFRT) of Breast/Chest Wall and Regional Nodes in Locally Advanced Breast Cancer: Toxicity Profile and Survival Outcomes in Retrospective Monoistitutional Study.
    De Matteis S; Facondo G; Valeriani M; Vullo G; De Sanctis V; Ascolese AM; Campanella B; Scalabrino G; Osti MF
    Clin Breast Cancer; 2022 Apr; 22(3):e332-e340. PubMed ID: 34670727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two hypofractionated radiotherapy schedules in locally advanced postmastectomy breast cancer patients.
    Choudhary S; Gupta N; Misra S; Munnee NN; Kumar A; Ranjan R; Dhar SS; Kumar D; Mourya A; Aggarwal LM
    J Cancer Res Ther; 2020; 16(6):1331-1335. PubMed ID: 33342792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Favorable safety profile of moderate hypofractionated over normofractionated radiotherapy in breast cancer patients: a multicentric prospective real-life data farming analysis.
    Issoufaly I; Petit C; Guihard S; Eugène R; Jung L; Clavier JB; Servagi Vernat S; Bellefqih S; Verret B; Bonnet N; Deutsch É; Rivera S
    Radiat Oncol; 2022 Apr; 17(1):80. PubMed ID: 35443729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preliminary results of whole breast helical tomotherapy with simultaneous integrated boost in the adjuvant treatment of breast cancer].
    Liem X; Chira C; Fourquet A; Campana F; Peurien D; Fournier-Bidoz N; Kirova YM
    Cancer Radiother; 2014 Jan; 18(1):15-22. PubMed ID: 24316350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.
    Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F
    Breast J; 2011; 17(6):586-93. PubMed ID: 21951485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short tangential arcs in VMAT based breast and chest wall radiotherapy lead to conformity of the breast dose with lesser cardiac and lung doses: a prospective study of breast conservation and mastectomy patients.
    Munshi A; Sarkar B; Anbazhagan S; Giri UK; Kaur H; Jassal K; Ganesh T; Kalyan Mohanti B
    Australas Phys Eng Sci Med; 2017 Sep; 40(3):729-736. PubMed ID: 28523470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypofractionated irradiation of infra-supraclavicular lymph nodes after axillary dissection in patients with breast cancer post-conservative surgery: impact on late toxicity.
    Guenzi M; Blandino G; Vidili MG; Aloi D; Configliacco E; Verzanini E; Tornari E; Cavagnetto F; Corvò R
    Radiat Oncol; 2015 Aug; 10():177. PubMed ID: 26289040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetry and outcomes in patients receiving radiotherapy for synchronous bilateral breast cancers.
    McKenzie E; Razvi Y; Bosnic S; Wronski M; Zhang L; Karam I; Donovan E; Milton L; Behroozian T; Drost L; Yee C; Wong G; Lam E; Chow E
    J Med Imaging Radiat Sci; 2021 Dec; 52(4):527-543. PubMed ID: 34580051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early toxicity in patients treated with postoperative proton therapy for locally advanced breast cancer.
    Cuaron JJ; Chon B; Tsai H; Goenka A; DeBlois D; Ho A; Powell S; Hug E; Cahlon O
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):284-91. PubMed ID: 25754632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetric comparison of conventional and forward-planned intensity-modulated techniques for comprehensive locoregional irradiation of post-mastectomy left breast cancers.
    Cavey ML; Bayouth JE; Endres EJ; Pena JM; Colman M; Hatch S
    Med Dosim; 2005; 30(2):107-16. PubMed ID: 15922178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes Following a Moderately Hypofractionated Adjuvant Radiation (START B Type) Schedule for Breast Cancer in an Unscreened Non-Caucasian Population.
    Chatterjee S; Arunsingh M; Agrawal S; Dabkara D; Mahata A; Arun I; Shrimali RK; Achari R; Mallick I; Ahmed R
    Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):e165-72. PubMed ID: 27369459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel 10-fraction breast irradiation in prone and supine position: technical, dosimetric and clinical evaluation.
    Guenzi M; Bosetti D; Lamanna G; Siffredi G; Bonzano E; Gusinu M; Garelli S; Pupillo F; Corvò R
    Tumori; 2015; 101(2):154-60. PubMed ID: 25838252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC): a short, safe, and effective postoperative regimen for high-risk breast cancer patients.
    Koukourakis MI; Giatromanolaki A; Kouroussis C; Kakolyris S; Sivridis E; Frangiadaki C; Retalis G; Georgoulias V;
    Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):144-55. PubMed ID: 11777632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant chemotherapy and acute toxicity in hypofractionated radiotherapy for early breast cancer.
    Kouloulias V; Zygogianni A; Kypraiou E; Georgakopoulos J; Thrapsanioti Z; Beli I; Mosa E; Psyrri A; Antypas C; Armbilia C; Tolia M; Platoni K; Papadimitriou C; Arkadopoulos N; Gennatas C; Zografos G; Kyrgias G; Dilvoi M; Patatoucas G; Kelekis N; Kouvaris J
    World J Clin Cases; 2014 Nov; 2(11):705-10. PubMed ID: 25405195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent use of aromatase inhibitors and hypofractionated radiation therapy.
    Chargari C; Castro-Pena P; Toledano I; Bollet MA; Savignoni A; Cottu P; Laki F; Campana F; De Cremoux P; Fourquet A; Kirova YM
    World J Radiol; 2012 Jul; 4(7):318-23. PubMed ID: 22900133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.